Carlyle was looking at selling 6% of its for ₹1,750 crore in Piramal Pharma via a block deal. CNBC-TV18 had reported regarding the same on Thursday. However, sources on Friday said the block deal had been cancelled.
Carlyle was looking at selling 6% of its for ₹1,750 crore in Piramal Pharma via a block deal. CNBC-TV18 had reported regarding the same on Thursday. However, sources on Friday said the block deal had been cancelled.